Cartilage has no meaningful capacity to heal itself once damaged—a biological limitation that makes joint degeneration progressive and difficult to reverse through conventional treatment alone. Stem cell therapy for joints aims to address this directly, using the body’s own regenerative cells to target cartilage damage, osteoarthritis, and soft tissue injuries. In Singapore, this regenerative approach has become increasingly available through orthopaedic practices, offering patients an option between conservative management and surgical intervention. The procedure involves harvesting cells from bone marrow or adipose tissue, processing them, and injecting them directly into damaged joint structures where they may support tissue repair and reduce inflammation.
Unlike traditional treatments that manage symptoms, stem cell therapy aims to modify the underlying joint environment. The cells release growth factors and anti-inflammatory proteins that may help slow cartilage breakdown while potentially stimulating new tissue formation. Results vary considerably between patients depending on age, extent of damage, and which joint is treated. Stem cell therapy for joints in Singapore follows strict protocols established by medical regulatory bodies, ensuring standardised processing and administration techniques across certified facilities.
How Joint Stem Cell Therapy Works
Mesenchymal stem cells possess the ability to differentiate into various tissue types, including cartilage, bone, and tendon. When introduced into a damaged joint, these cells are believed to respond to local chemical signals that guide their behaviour. Rather than simply replacing worn cartilage cell-for-cell, the injected stem cells aim to create a regenerative microenvironment through paracrine signalling—releasing proteins that influence surrounding tissues.
The inflammatory cascade present in arthritic joints normally accelerates tissue breakdown. Stem cells may help modulate this process by secreting anti-inflammatory cytokines aiming to interrupt destructive pathways. Simultaneously, they release growth factors including transforming growth factor-beta and insulin-like growth factor, which may encourage existing cartilage cells to produce new extracellular matrix components.
Joint surfaces contain limited blood supply, which restricts natural healing capacity. Stem cell preparations aim to address this by supporting angiogenesis—the formation of new blood vessels—potentially improving nutrient delivery to previously avascular regions. This enhanced circulation supports ongoing repair processes beyond the initial treatment period.
Cell Harvesting Methods
Bone Marrow Aspiration
Bone marrow provides a rich source of mesenchymal stem cells along with other regenerative components. The iliac crest (hip bone) serves as the standard harvest site due to its accessibility and high cell concentration. Under local anaesthesia, a specialised needle extracts marrow containing stem cells, platelets, and growth factors. The procedure takes approximately 30 minutes and causes temporary soreness at the collection site lasting several days.
The harvested marrow undergoes centrifugation to concentrate the cellular components. This processing separates red blood cells from the stem cell-rich fraction, creating bone marrow aspirate concentrate (BMAC) ready for injection. Same-day processing helps maintain cell viability.
Adipose Tissue Extraction
Fat tissue contains abundant mesenchymal stem cells in a form called stromal vascular fraction. A mini-liposuction procedure removes a small volume of fat from the abdomen or thigh under local anaesthesia. The tissue then undergoes enzymatic digestion or mechanical processing to release the cellular components.
Adipose-derived cells offer certain practical advantages: harvest causes minimal discomfort, fat tissue yields high cell numbers, and the extraction site heals quickly. However, regulatory frameworks in Singapore govern which processing methods qualify as point-of-care procedures versus those requiring additional licensing.
Conditions Treated with Joint Stem Cells
Knee osteoarthritis represents the most common indication for stem cell therapy. Patients with mild to moderate cartilage loss who wish to delay or avoid knee replacement surgery often explore this option. The treatment aims to target both the structural damage and the inflammatory component driving symptom progression.
Hip joint degeneration may respond to stem cell injection, though outcomes depend heavily on the pattern and severity of cartilage loss. Focal defects in weight-bearing areas may show more improvement than diffuse pan-joint involvement.
Shoulder conditions including rotator cuff tears and glenohumeral arthritis may benefit from the anti-inflammatory and tissue-supporting effects. Partial thickness rotator cuff tears in particular may experience improved healing when combined with appropriate rehabilitation.
Hand and wrist arthritis affecting the carpometacarpal joint, scaphotrapeziotrapezoid joint, or radiocarpal joint may be addressed with stem cell injection. The smaller joint volumes require precise injection technique, often performed under ultrasound or fluoroscopic guidance.
Ankle osteoarthritis following previous injury or instability presents treatment challenges due to the joint’s limited tolerance for cartilage loss. Stem cell therapy offers a joint-preserving option for appropriately selected patients.
The Treatment Process
Initial evaluation includes physical examination, imaging review, and detailed discussion of expectations. MRI provides useful information about cartilage thickness, bone marrow changes, and associated soft tissue pathology. Patients with severe bone-on-bone arthritis or significant mechanical deformity typically achieve limited benefit from stem cell therapy alone.
On treatment day, the harvesting procedure occurs first—either bone marrow aspiration or adipose collection depending on the planned protocol. While the sample undergoes processing, the target joint receives local anaesthetic. The concentrated cell preparation is then injected using image guidance to help ensure accurate placement within the joint space or specific defect area.
Post-procedure protocols vary between practitioners but generally involve initial rest followed by gradual activity progression. Weight-bearing restrictions may apply for lower limb joints during the first weeks. Physical therapy begins once initial healing occurs, focusing on range of motion preservation and strength rebuilding.
💡 Did You Know?
Mesenchymal stem cells demonstrate immunomodulatory properties, meaning they can regulate immune responses. This characteristic may allow them to help reduce inflammation without suppressing beneficial immune functions—a selective effect that differs from synthetic medications.
Factors Affecting Treatment Outcomes
Age influences both the quality of harvested cells and the joint’s response to treatment. Stem cells from younger patients demonstrate greater proliferative capacity and differentiation potential. However, older patients may still benefit, particularly when cell processing techniques optimise the preparation.
Body weight affects mechanical stress on treated joints. Patients with elevated BMI experience higher forces through weight-bearing joints, potentially affecting regenerative outcomes. Weight management supports treatment and long-term joint preservation.
Activity level and occupation determine ongoing joint stress. Manual labourers or athletes face different demands than sedentary individuals. Treatment planning must account for anticipated mechanical loading during and after recovery.
Disease severity at treatment time significantly impacts results. Early to moderate arthritis typically responds more favourably than advanced disease with significant bone changes. Timing of intervention affects potential benefit.
Concurrent conditions including diabetes, autoimmune disorders, and smoking affect healing capacity. Optimising systemic health before treatment may improve outcomes.
What to Expect After Treatment
Initial joint swelling commonly occurs during the first week as the injected cells and associated fluid create temporary volume increase. This resolves spontaneously and does not indicate treatment failure. Mild discomfort at the harvest site persists for several days.
Symptom improvement follows a variable timeline. Some patients notice reduced pain within weeks, while others require several months before appreciating meaningful change. The biological processes underlying tissue modification occur gradually—cartilage matrix production and remodelling cannot happen overnight.
Clinical assessment at three months provides initial indication of treatment response. Continued improvement may occur through twelve months as regenerative processes mature. Repeat imaging at one year documents structural changes when present.
Combining Therapies
Platelet-rich plasma can be administered alongside or following stem cell injection. Platelets release concentrated growth factors that may support stem cell survival and activity. Some protocols utilise PRP as a follow-up injection several weeks after the primary stem cell treatment.
Hyaluronic acid supplementation can help improve joint lubrication and may create a more favourable environment for stem cell function. Timing of viscosupplementation relative to stem cell injection varies between treatment protocols.
Structured rehabilitation is an important component regardless of which biological therapy is utilised. Exercise helps maintain joint mobility, strengthen supporting muscles, and provide mechanical stimulation that influences cartilage metabolism. Neglecting rehabilitation may limit treatment outcomes.
⚠️ Important Note
Stem cell therapy does not reverse established bone changes including osteophyte formation or subchondral cysts. These structural alterations may continue causing symptoms even if cartilage quality improves. Treatment discussions should address realistic expectations based on current imaging findings.
What Our Orthopaedic Specialist Says
Clinical experience indicates that patient selection significantly influences satisfaction rates. Those with focal cartilage defects and preserved joint space typically report greater improvement than patients with diffuse end-stage arthritis. Setting appropriate expectations during consultation allows patients to make informed decisions aligned with their circumstances and goals.
The regenerative medicine field continues to evolve. Current techniques represent meaningful progress over previous approaches, though further refinements will likely emerge. Patients considering treatment should understand both present capabilities and the developing nature of the field.
Putting This Into Practice
- Complete a medication review several weeks before the procedure. Certain anti-inflammatory drugs may interfere with stem cell function and require temporary discontinuation. Blood thinning medications need adjustment based on bleeding risk assessment.
- Arrange transportation and assistance for treatment day. Sedation is not typically required, but driving immediately afterward is inadvisable. Plan for reduced mobility during initial recovery, particularly for lower limb procedures.
- Optimise overall health in the weeks preceding treatment. Adequate sleep, balanced nutrition, and smoking cessation support cellular function. Managing blood glucose in diabetic patients may improve healing responses.
- Prepare the home environment with necessary mobility aids. Crutches or a walker may be recommended for knee, hip, or ankle procedures. Having these items ready before treatment day reduces stress.
- Complete recommended exercises provided during consultation. Pre-treatment conditioning may improve post-procedure rehabilitation outcomes. Stronger muscles provide better joint support during recovery.
When to Seek Professional Help
- Joint pain persisting beyond several weeks despite conservative measures
- Stiffness limiting daily activities or work requirements
- Previous injury with ongoing symptoms suggestive of cartilage damage
- Arthritis diagnosis with inadequate response to standard treatments
- Interest in joint preservation options before considering replacement surgery
- Swelling that recurs repeatedly after activity
Commonly Asked Questions
How long do stem cell therapy results last?
Duration varies between patients based on disease severity, activity level, and biological response. Published follow-up data extends to several years, with many patients maintaining improvement throughout this period. Some patients pursue repeat treatment when benefits diminish, though optimal retreatment intervals remain under investigation.
Is stem cell therapy painful?
The harvesting procedure causes temporary discomfort managed with local anaesthesia. Most patients describe the sensation as pressure rather than sharp pain. Joint injection itself causes brief stinging that resolves within minutes. Post-procedure soreness responds to standard pain relief measures.
How does this compare to joint replacement surgery?
These treatments serve different purposes. Joint replacement provides a definitive mechanical solution for end-stage arthritis but involves longer recovery and irreversible alteration. Stem cell therapy attempts joint preservation with minimal downtime. Many patients view regenerative treatment as an intermediate step, potentially delaying eventual surgery.
What happens if the treatment doesn’t work?
Non-response does not preclude other treatments. Patients retain all surgical options if stem cell therapy provides insufficient benefit. Some patients pursue repeat injection with modified protocols, while others proceed to alternative interventions based on reassessment findings.
Am I a suitable candidate?
Candidacy depends on multiple factors including joint involved, disease stage, overall health, and treatment goals. Detailed evaluation with imaging review determines appropriateness. Patients with very advanced arthritis or significant deformity generally achieve limited benefit from stem cell therapy alone.
Next Steps
Stem cell therapy generally shows the greatest benefit in patients with mild to moderate cartilage loss and preserved joint space—not those with advanced bone-on-bone arthritis. Outcomes depend on accurate patient selection, quality cell preparation, and consistent post-treatment rehabilitation. A comprehensive orthopaedic evaluation with current imaging is required to determine whether this treatment is appropriate for your specific joint condition.
If you are experiencing persistent joint pain or stiffness, have been diagnosed with cartilage damage or osteoarthritis, or are considering joint preservation options before replacement surgery, consult our orthopaedic surgeon to determine whether stem cell therapy is appropriate for your condition.
Experiencing Hand, Wrist or Upper Limb Pain?
Get a Personalised Treatment Plan
Find relief with our specialist hand surgeon.
Make An Enquiry
